Companion Diagnostics Market
Buy Now Request Sample Explore
Home › Report Store › Life Sciences  › Companion Diagnostics Market

Companion Diagnostics Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Companion Diagnostics Market size was valued at US$ 11.2 Billion in 2025 and is projected to reach US$ 30.61 Billion by 2033, growing at a CAGR of 13.39% during 2026–2033. Growth is supported by precision oncology adoption, expanding biomarker-based therapies, increasing regulatory approvals, pharmaceutical-diagnostic collaborations, and opportunities emerging from next-generation sequencing, liquid biopsy, and personalized medicine programs.

Report Coverage
  • Technology: Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization, Next Generation Gene Sequencing, Others
  • Indication: Cancer, Neurological Diseases, Infectious Diseases, Others
  • End-user: Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others
US$ 11.2 Bn Market size in 2025
US$ 30.61 Bn Market Size by 2033
13.39% CAGR, 2026 - 2033
2026-2033 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Companion Diagnostics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Companion Diagnostics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Companion Diagnostics Market Global Analysis

6.2 Companion Diagnostics Market Revenue 2022-2033 (US$ Billion)
6.3 Companion Diagnostics Market Forecast Analysis

7. Companion Diagnostics Market Analysis – by Technology

7.1 Polymerase Chain Reaction
  • 7.1.1 Overview
  • 7.1.2 Polymerase Chain Reaction: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.2 Immunohistochemistry
  • 7.2.1 Overview
  • 7.2.2 Immunohistochemistry: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.3 In-situ Hybridization
  • 7.3.1 Overview
  • 7.3.2 In-situ Hybridization: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.4 Next Generation Gene Sequencing
  • 7.4.1 Overview
  • 7.4.2 Next Generation Gene Sequencing: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.5 Others
  • 7.5.1 Overview
  • 7.5.2 Others: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Companion Diagnostics Market Analysis – by Indication

8.1 Cancer
  • 8.1.1 Overview
  • 8.1.2 Cancer: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.2 Neurological Diseases
  • 8.2.1 Overview
  • 8.2.2 Neurological Diseases: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.3 Infectious Diseases
  • 8.3.1 Overview
  • 8.3.2 Infectious Diseases: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.4 Others
  • 8.4.1 Overview
  • 8.4.2 Others: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Companion Diagnostics Market Analysis – by End-user

9.1 Pharmaceutical & Biopharmaceutical Companies
  • 9.1.1 Overview
  • 9.1.2 Pharmaceutical & Biopharmaceutical Companies: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.2 Reference Laboratories
  • 9.2.1 Overview
  • 9.2.2 Reference Laboratories: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.3 Contract Research Organizations
  • 9.3.1 Overview
  • 9.3.2 Contract Research Organizations: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.4 Others
  • 9.4.1 Overview
  • 9.4.2 Others: Companion Diagnostics Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. Companion Diagnostics Market – Geographic Analysis

10.1 Overview

10.2 North America
  • 10.2.1 Companion Diagnostics Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.2.1.1 Companion Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 US: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.2.1.1.1 US: Companion Diagnostics Market Breakdown, by Technology
    • 10.2.1.1.2 US: Companion Diagnostics Market Breakdown, by Indication
    • 10.2.1.1.3 US: Companion Diagnostics Market Breakdown, by End-user
  • 10.2.1.2 Canada: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.2.1.2.1 Canada: Companion Diagnostics Market Breakdown, by Technology
    • 10.2.1.2.2 Canada: Companion Diagnostics Market Breakdown, by Indication
    • 10.2.1.2.3 Canada: Companion Diagnostics Market Breakdown, by End-user
  • 10.2.1.3 Mexico: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.2.1.3.1 Mexico: Companion Diagnostics Market Breakdown, by Technology
    • 10.2.1.3.2 Mexico: Companion Diagnostics Market Breakdown, by Indication
    • 10.2.1.3.3 Mexico: Companion Diagnostics Market Breakdown, by End-user
10.3 Europe
  • 10.3.1 Companion Diagnostics Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.3.1.1 Companion Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.3.1.1 Germany: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.1.1 Germany: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.1.2 Germany: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.1.3 Germany: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.2 Italy: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.2.1 Italy: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.2.2 Italy: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.2.3 Italy: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.3 France: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.3.1 France: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.3.2 France: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.3.3 France: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.4 U.K.: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.4.1 U.K.: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.4.2 U.K.: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.4.3 U.K.: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.5 Spain: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.5.1 Spain: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.5.2 Spain: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.5.3 Spain: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.6 Belgium: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.6.1 Belgium: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.6.2 Belgium: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.6.3 Belgium: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.7 Netherlands: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.7.1 Netherlands: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.7.2 Netherlands: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.7.3 Netherlands: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.8 Luxembourg: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.8.1 Luxembourg: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.8.2 Luxembourg: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.8.3 Luxembourg: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.9 Norway: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.9.1 Norway: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.9.2 Norway: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.9.3 Norway: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.10 Finland: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.10.1 Finland: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.10.2 Finland: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.10.3 Finland: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.11 Denmark: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.11.1 Denmark: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.11.2 Denmark: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.11.3 Denmark: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.12 Sweden: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.12.1 Sweden: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.12.2 Sweden: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.12.3 Sweden: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.13 Switzerland: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.13.1 Switzerland: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.13.2 Switzerland: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.13.3 Switzerland: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.14 Austria: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.14.1 Austria: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.14.2 Austria: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.14.3 Austria: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.15 Greece: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.15.1 Greece: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.15.2 Greece: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.15.3 Greece: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.16 Portugal: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.16.1 Portugal: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.16.2 Portugal: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.16.3 Portugal: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.17 Russia: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.17.1 Russia: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.17.2 Russia: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.17.3 Russia: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.18 Poland: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.18.1 Poland: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.18.2 Poland: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.18.3 Poland: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.19 Romania: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.19.1 Romania: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.19.2 Romania: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.19.3 Romania: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.20 Czech Republic: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.20.1 Czech Republic: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.20.2 Czech Republic: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.20.3 Czech Republic: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.21 Ukraine: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.21.1 Ukraine: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.21.2 Ukraine: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.21.3 Ukraine: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.22 Slovakia: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.22.1 Slovakia: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.22.2 Slovakia: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.22.3 Slovakia: Companion Diagnostics Market Breakdown, by End-user
  • 10.3.1.23 Bulgaria: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.23.1 Bulgaria: Companion Diagnostics Market Breakdown, by Technology
    • 10.3.1.23.2 Bulgaria: Companion Diagnostics Market Breakdown, by Indication
    • 10.3.1.23.3 Bulgaria: Companion Diagnostics Market Breakdown, by End-user
10.4 Asia-Pacific
  • 10.4.1 Companion Diagnostics Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.4.1.1 Companion Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.4.1.1 China: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.1.1 China: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.1.2 China: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.1.3 China: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.2 Japan: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.2.1 Japan: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.2.2 Japan: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.2.3 Japan: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.3 South Korea: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.3.1 South Korea: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.3.2 South Korea: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.3.3 South Korea: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.4 India: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.4.1 India: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.4.2 India: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.4.3 India: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.5 Australia: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.5.1 Australia: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.5.2 Australia: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.5.3 Australia: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.6 New Zealand: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.6.1 New Zealand: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.6.2 New Zealand: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.6.3 New Zealand: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.7 Indonesia: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.7.1 Indonesia: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.7.2 Indonesia: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.7.3 Indonesia: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.8 Malaysia: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.8.1 Malaysia: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.8.2 Malaysia: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.8.3 Malaysia: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.9 Philippines: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.9.1 Philippines: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.9.2 Philippines: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.9.3 Philippines: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.10 Singapore: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.10.1 Singapore: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.10.2 Singapore: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.10.3 Singapore: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.11 Thailand: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.11.1 Thailand: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.11.2 Thailand: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.11.3 Thailand: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.12 Vietnam: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.12.1 Vietnam: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.12.2 Vietnam: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.12.3 Vietnam: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.13 Taiwan: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.13.1 Taiwan: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.13.2 Taiwan: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.13.3 Taiwan: Companion Diagnostics Market Breakdown, by End-user
  • 10.4.1.14 Bangladesh: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.14.1 Bangladesh: Companion Diagnostics Market Breakdown, by Technology
    • 10.4.1.14.2 Bangladesh: Companion Diagnostics Market Breakdown, by Indication
    • 10.4.1.14.3 Bangladesh: Companion Diagnostics Market Breakdown, by End-user
10.5 South and Central America
  • 10.5.1 Companion Diagnostics Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.5.1.1 Companion Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.5.1.1 Brazil: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.5.1.1.1 Brazil: Companion Diagnostics Market Breakdown, by Technology
    • 10.5.1.1.2 Brazil: Companion Diagnostics Market Breakdown, by Indication
    • 10.5.1.1.3 Brazil: Companion Diagnostics Market Breakdown, by End-user
  • 10.5.1.2 Argentina: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.5.1.2.1 Argentina: Companion Diagnostics Market Breakdown, by Technology
    • 10.5.1.2.2 Argentina: Companion Diagnostics Market Breakdown, by Indication
    • 10.5.1.2.3 Argentina: Companion Diagnostics Market Breakdown, by End-user
  • 10.5.1.3 Chile: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.5.1.3.1 Chile: Companion Diagnostics Market Breakdown, by Technology
    • 10.5.1.3.2 Chile: Companion Diagnostics Market Breakdown, by Indication
    • 10.5.1.3.3 Chile: Companion Diagnostics Market Breakdown, by End-user
  • 10.5.1.4 Colombia: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.5.1.4.1 Colombia: Companion Diagnostics Market Breakdown, by Technology
    • 10.5.1.4.2 Colombia: Companion Diagnostics Market Breakdown, by Indication
    • 10.5.1.4.3 Colombia: Companion Diagnostics Market Breakdown, by End-user
  • 10.5.1.5 Peru: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.5.1.5.1 Peru: Companion Diagnostics Market Breakdown, by Technology
    • 10.5.1.5.2 Peru: Companion Diagnostics Market Breakdown, by Indication
    • 10.5.1.5.3 Peru: Companion Diagnostics Market Breakdown, by End-user
10.6 Middle East and Africa
  • 10.6.1 Companion Diagnostics Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.6.1.1 Companion Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.6.1.1 Saudi Arabia: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.1.1 Saudi Arabia: Companion Diagnostics Market Breakdown, by Technology
    • 10.6.1.1.2 Saudi Arabia: Companion Diagnostics Market Breakdown, by Indication
    • 10.6.1.1.3 Saudi Arabia: Companion Diagnostics Market Breakdown, by End-user
  • 10.6.1.2 United Arab Emirates: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.2.1 United Arab Emirates: Companion Diagnostics Market Breakdown, by Technology
    • 10.6.1.2.2 United Arab Emirates: Companion Diagnostics Market Breakdown, by Indication
    • 10.6.1.2.3 United Arab Emirates: Companion Diagnostics Market Breakdown, by End-user
  • 10.6.1.3 Kuwait: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.3.1 Kuwait: Companion Diagnostics Market Breakdown, by Technology
    • 10.6.1.3.2 Kuwait: Companion Diagnostics Market Breakdown, by Indication
    • 10.6.1.3.3 Kuwait: Companion Diagnostics Market Breakdown, by End-user
  • 10.6.1.4 Bahrain: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.4.1 Bahrain: Companion Diagnostics Market Breakdown, by Technology
    • 10.6.1.4.2 Bahrain: Companion Diagnostics Market Breakdown, by Indication
    • 10.6.1.4.3 Bahrain: Companion Diagnostics Market Breakdown, by End-user
  • 10.6.1.5 Qatar: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.5.1 Qatar: Companion Diagnostics Market Breakdown, by Technology
    • 10.6.1.5.2 Qatar: Companion Diagnostics Market Breakdown, by Indication
    • 10.6.1.5.3 Qatar: Companion Diagnostics Market Breakdown, by End-user
  • 10.6.1.6 Oman: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.6.1 Oman: Companion Diagnostics Market Breakdown, by Technology
    • 10.6.1.6.2 Oman: Companion Diagnostics Market Breakdown, by Indication
    • 10.6.1.6.3 Oman: Companion Diagnostics Market Breakdown, by End-user
  • 10.6.1.7 Turkiye: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.7.1 Turkiye: Companion Diagnostics Market Breakdown, by Technology
    • 10.6.1.7.2 Turkiye: Companion Diagnostics Market Breakdown, by Indication
    • 10.6.1.7.3 Turkiye: Companion Diagnostics Market Breakdown, by End-user
  • 10.6.1.8 South Africa: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.8.1 South Africa: Companion Diagnostics Market Breakdown, by Technology
    • 10.6.1.8.2 South Africa: Companion Diagnostics Market Breakdown, by Indication
    • 10.6.1.8.3 South Africa: Companion Diagnostics Market Breakdown, by End-user
  • 10.6.1.9 Egypt: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.9.1 Egypt: Companion Diagnostics Market Breakdown, by Technology
    • 10.6.1.9.2 Egypt: Companion Diagnostics Market Breakdown, by Indication
    • 10.6.1.9.3 Egypt: Companion Diagnostics Market Breakdown, by End-user
  • 10.6.1.10 Nigeria: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.10.1 Nigeria: Companion Diagnostics Market Breakdown, by Technology
    • 10.6.1.10.2 Nigeria: Companion Diagnostics Market Breakdown, by Indication
    • 10.6.1.10.3 Nigeria: Companion Diagnostics Market Breakdown, by End-user
  • 10.6.1.11 Algeria: Companion Diagnostics Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.11.1 Algeria: Companion Diagnostics Market Breakdown, by Technology
    • 10.6.1.11.2 Algeria: Companion Diagnostics Market Breakdown, by Indication
    • 10.6.1.11.3 Algeria: Companion Diagnostics Market Breakdown, by End-user

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Foundation Medicine, Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 QIAGEN N.V.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Agilent Technologies, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Illumina, Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Abbott Laboratories
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Bio-Rad Laboratories, Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Danaher Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Guardant Health, Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

Access the Full C Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization
Access the full C Market Report
350 pages PDF & Excel | 2026-08-31
Download Sample Customization